Pharma Journalist - Page 14 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Latus Bio Raises $97 Million to Advance Gene Therapies

FDA Approves LANGLARA Biosimilar Insulin for Diabetes Treatment

UCB to Acquire Candid Therapeutics in $2.2 Billion Deal

FDA Expands Auvelity Use for Alzheimer’s Agitation Treatment

Novo Nordisk Launches Oral Ozempic for Type 2 Diabetes

Australia Approves First FCS Treatment REDEMPLO by Arrowhead

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal